DCT Tracker update: decentralised clinical trials to reach new peak
Clinical Trials Arena updates its exclusive DCT tracker and projects record trial decentralisation uptake after a minor respite in 2022.
Pipeline Moves: advancement prospects jump for cardiovascular gene therapy
Farewell EudraCT: all trial applications must now be submitted through EMA’s new portal
Mapping endpoints: building gene therapy trials for the future
Predictive analytics in drug development: state of play
Inclusive drugs: designing clinical trials for the pregnant population
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreMediciNova receives approval from Health Canada for long Covid therapy trial
The trial will assess MN-166 and other therapies for the treatment of long Covid patients.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Syneos and Haystack announce partnership to improve patient enrolment
GreenLight receives Rwanda FDA approval for Covid-19 mRNA vaccine trial
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Tevogen Bio reports positive data from Covid-19 T cell therapy trial